American College of Clinical Pharmacy AI policy
Varies by programChecked November 9, 2026
In short
For the ACCP Clinical Pharmacy Research Challenge, Letter of Intent guidance lists an acknowledgement section disclosing any use of AI. Teams must describe any tool used to generate text or images, and state clearly if no AI was used.
For applicants
- For the Clinical Pharmacy Research Challenge LOI, any tools that helped generate text or images must be described, including the specific tool and how it was used.[1]
- If AI tools helped with data analysis, the specific tool and what it did should be described in the methods section.[1]
- If no AI was used, the team must clearly say so in the acknowledgement section.[1]
Sources
- [1]Developing a Letter of Intent for the ACCP Clinical Pharmacy Research Challenge
American College of Clinical Pharmacy
“The use of tools that assisted the author(s) with generating text or images must be described. The description should include the specific tool and how it was used to create text or images used in the manuscript.”
“If AI tools were used to assist with data analysis, the specific tool and description of what it performed should be included in the methods section in the body of the manuscript.”
“If no use of Artificial Intelligence was employed the authors must clearly indicate so in the acknowledgement section.”
This page summarizes published guidance and is not legal advice. Policies change, and a specific solicitation can add its own rules, so confirm against the funding announcement before you apply. See every funder's AI policy.